Humans in Public Health

The East African country of Rwanda is currently in the midst of a Marburg virus disease outbreak, but the picture is far from bleak. Global health expert Dr. Craig Spencer, who survived Ebola in 2014, joined us to discuss the current situation in Rwanda, how the country has managed its “unprecedented” response, and what more developed nations can learn about global health security from their success.

The dangers of firearms are well understood, but their ammunition is the source of a little-known health threat: toxic lead. Brown doctoral student Christian Hoover studies the connection between guns and elevated blood lead levels in America’s children and adults. Host Megan Hall speaks with him about the results of the first national study of this problem, and his advice for gun owners on the healthiest way to minimize lead exposure.

In this summer replay of a previous episode, host Megan Hall speaks with Dr. Jud Brewer, associate professor of psychiatry at the Brown Medical School about anxiety. In uncertain times, how do we address fear and worry that grips us? How do we help our kids do the same?

Post traumatic stress disorder (PTSD) is one of the most common conditions facing U.S. Veterans, and there is currently no effective cure—what’s more, many Veterans use alcohol in an effort to alleviate their trauma, making their medical treatment even more complex. For these high risk patients, two professors at Brown are thinking outside the box: Could a treatment involving psychedelic drugs potentially save Veteran lives?

In this episode, Megan speaks to Professors Christy Capone and Carolina Haass-Koffler, part of a team at Brown running the first study of a promising new treatment that combines therapy with MDMA (aka the party drug molly, or ecstasy) for Veterans with PTSD and alcohol use disorder. The researchers explain the science guiding their study, why they believe this treatment could be a game-changer and the upcoming FDA decision regarding MDMA’s role in medicine.